Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mercury General | MCY | Nov 25, 2024 | 77.77 | +0.65 |
Mercury Systems | MRCY | Nov 25, 2024 | 40.94 | 0.00 |
Mereo BioPharma ADR | MREO | Nov 25, 2024 | 3.38 | -9.14 |
Meridian | MRBK | Nov 25, 2024 | 16.31 | +5.23 |
MeridianLink | MLNK | Nov 25, 2024 | 23.00 | +0.44 |
Merit Medical Systems | MMSI | Nov 25, 2024 | 104.92 | -0.39 |
Meritage Homes | MTH | Nov 25, 2024 | 195.86 | +6.19 |
Merrill Lynch & Co. | IPB | Nov 25, 2024 | 25.71 | -0.35 |
Mersana Therapeutics | MRSN | Nov 25, 2024 | 2.00 | -1.96 |
Merus N.V | MRUS | Nov 25, 2024 | 45.39 | -0.22 |
Mesa Air Group | MESA | Nov 25, 2024 | 0.98 | +12.29 |
Mesa Laboratories | MLAB | Nov 25, 2024 | 113.62 | +4.15 |
Mesa Royalty Trust | MTR | Nov 25, 2024 | 7.20 | -0.83 |
Mesabi Royalty Trust | MSB | Nov 25, 2024 | 25.78 | -0.96 |
Mesoblast ADR | MESO | Nov 25, 2024 | 11.03 | +9.10 |
Meta Materials | MMAT | Nov 25, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Nov 25, 2024 | 565.11 | +1.07 |
Metagenomi | MGX | Nov 25, 2024 | 2.01 | +6.35 |
Metal Sky Star Acquisition | MSSA | Nov 25, 2024 | 11.67 | 0.00 |
Metalla Royalty & Streaming | MTA | Nov 25, 2024 | 3.04 | -2.88 |
Metallus | MTUS | Nov 25, 2024 | 16.18 | +4.12 |
Metals Acquisition | MTAL | Nov 25, 2024 | 12.50 | -2.19 |
Methalpa Technology Holding | MATH | Nov 25, 2024 | 0.93 | -6.16 |
Methanex | MEOH | Nov 25, 2024 | 46.91 | +1.93 |
Methode Electronics | MEI | Nov 25, 2024 | 10.69 | +2.10 |
MetLife | MET | Nov 25, 2024 | 87.34 | +0.87 |
Metlife Pref A | MET-A | Nov 25, 2024 | 24.53 | 0.00 |
Metlife Pref E | MET-E | Nov 25, 2024 | 24.37 | +0.33 |
Metlife Pref F | MET-F | Nov 25, 2024 | 21.33 | +0.19 |
MetroCity Bankshares | MCBS | Nov 25, 2024 | 35.27 | +0.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.